Oligodendrocyte dysfunction in schizophrenia and bipolar disorder

Lancet

Volumn 362, Issue 9386, 2003, Pages 798-805

  Tkachev, Dmitri ^a,c   Mimmack, Michael L ^a,c   Ryan, Margaret M ^a,c   Wayland, Matt ^b   Freeman, Tom ^b   Jones, Peter B ^c   Starkey, Michael ^b   Webster, Maree J ^d   Yolken, Robert H ^e   Bahn, Sabine ^a,c,f  

^a BABRAHAM INSTITUTE   (United Kingdom)

^b Genome Campus Hinxton   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; CORRELATION ANALYSIS; DIFFERENTIAL DISPLAY; DNA MICROARRAY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MYELINATION; NUCLEOTIDE SEQUENCE; OLIGODENDROGLIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCHIZOPHRENIA; VALIDATION PROCESS;

EID: 0041328892     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)14289-4     Document Type: Article

References (37)

1. Hakak Y., Walker J.R., Li C., et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci USA. 98:2001;4746-4751.
2. Pongrac J., Middleton F.A., Lewis D.A., Levitt P., Mirnics K. Gene expression profiling with DNA microarrays: advancing our understanding of psychiatric disorders. Neurochem Res. 27:2002;1049-1063.
3. Mimmack M.L., Ryan M., Baba H., et al. Gene expression analysis in schizophrenia: reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22. Proc Natl Acad Sci USA. 99:2002;4680-4685.
4. Horrobin D.F., Bennett C.N. New gene targets related to schizophrenia and other psychiatric disorders: enzymes, binding proteins and transport proteins involved in phospholipid and fatty acid metabolism. Prostaglandins Leukot Essent Fatty Acids. 60:1999;141-167.
5. Foong J., Maier M., Barker G.J., Brocklehurst S., Miller D.H., Ron M.A. In vivo investigation of white matter pathology in schizophrenia with magnetisation transfer imaging. J Neurol Neurosurg Psychiatry. 68:2000;70-74.
6. Lim K.O., Hedehus M., Moseley M., de Crespigny A., Sullivan E.V., Pfefferbaum A. Compromised white matter tract integrity in schizophrenia inferred from diffusion tensor imaging. Arch Gen Psychiatry. 56:1999;367-374.
7. Buchsbaum M.S., Tang C.Y., Peled S., et al. MRI white matter diffusion anisotropy and PET metabolic rate in schizophrenia. Neuroreport. 9:1998;425-430.
8. Torrey E.F., Webster M., Knable M., Johnston N., Yolken R.H. The Stanley foundation brain collection and neuropathology consortium. Schizophr Res. 44:2000;151-155.
9. Bahn S., Mimmack M., Ryan M., et al. Neuronal target genes of the neuron-restrictive silencer factor in neurospheres derived from fetuses with Down's syndrome: a gene expression study. Lancet. 359:2002;310-315.
10. Laboratory of Cognitive and Developmental Neuroscience. http://www.babraham.ac.uk/research/neurobiology/bahn.htm (accessed Aug 15, 2003).
11. Maziade M., Bissonnette L., Rouillard E., et al. 6p24-22 region and major psychoses in the Eastern Quebec population. Am J Med Genet. 74:1997;311-318.
12. Stefansson H., Sigurdsson E., Steinthorsdottir V., et al. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet. 71:2002;877-892.
13. Connor J.R. Iron acquisition and expression of iron regulatory proteins in the developing brain: manipulation by ethanol exposure, iron deprivation and cellular dysfunction. Dev Neurosci. 16:1994;233-247.
14. Erikson K.M., Pinero D.J., Connor J.R., Beard J.L. Regional brain iron, ferritin and transferrin concentrations during iron deficiency and iron repletion in developing rats. J Nutr. 127:1997;2030-2038.
15. Baumann N., Pham-Dinh D. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev. 81:2001;871-927.
16. Woodruff R.H., Tekki-Kessaris N., Stiles C.D., Rowitch D.H., Richardson W.D. Oligodendrocyte development in the spinal cord and telencephalon: common themes and new perspectives. Int J Dev Neurosci. 19:2001;379-385.
17. Lu Q.R., Park J.K., Noll E., et al. Oligodendrocyte lineage genes (OLIG) as molecular markers for human glial brain tumors. Proc Natl Acad Sci USA. 98:2001;10851-10856.
18. Zhou Q., Anderson D.J. The bHLH transcription factors OLIG2 and OLIG1 couple neuronal and glial subtype specification. Cell. 109:2002;61-73.
19. Kuhlbrodt K., Herbarth B., Sock E., Hermans-Borgmeyer I., Wegner M. Sox10, a novel transcriptional modulator in glial cells. J Neurosci. 18:1998;237-250.
20. Stolt C.C., Rehberg S., Ader M., et al. Terminal differentiation of myelin-forming oligodendrocytes depends on the transcription factor Sox10. Genes Dev. 16:2002;165-170.
21. Snider J.V., Wechser M.A., Lossos I.S. Human disease characterization: real-time quantitative PCR analysis of gene expression. Drug Discov Today. 6:2001;1062-1067.
22. Mayanil C.S., George D., Freilich L., et al. Microarray analysis detects novel Pax3 downstream target genes. J Biol Chem. 276:2001;49299-49309.
23. Wurmbach E., Yuen T., Ebersole B.J., Sealfon S.C. Gonadotropin-releasing hormone receptor-coupled gene network organization. J Biol Chem. 276:2001;47195-47201.
24. Gottesman I.I., McGuffin P., Farmer A.E. Clinical genetics as clues to the "real" genetics of schizophrenia (a decade of modest gains while playing for time). Schizophr Bull. 13:1987;23-47.
25. Benes F.M., Davidson J., Bird E.D. Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics. Arch Gen Psychiatry. 43:1986;31-35.
26. Yool D.A., Edgar J.M., Montague P., Malcolm S. The proteolipid protein gene and myelin disorders in man and animal models. Hum Mol Genet. 9:2000;987-992.
27. Marcus J., Dupree J.L., Popko B. Myelin-associated glycoprotein and myelin galactolipids stabilize developing axo-glial interactions. J Cell Biol. 156:2002;567-577.
28. Uranova N., Orlovskaya D., Vikhreva O., et al. Electron microscopy of oligodendroglia in severe mental illness. Brain Res Bull. 55:2001;597-610.
29. Hof P.R., Haroutunian V., Copland C., Davis K.L., Buxbaum J.D. Molecular and cellular evidence for an oligodendrocyte abnormality in schizophrenia. Neurochem Res. 27:2002;1193-1200.
30. Garbern J.Y., Yool D.A., Moore G.J., et al. Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation. Brain. 125:2002;551-561.
31. Bertolino A., Callicott J.H., Elman I., et al. Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study. Biol Psychiatry. 43:1998;641-648.
32. Bertolino A., Callicott J.H., Mattay V.S., et al. The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia. Biol Psychiatry. 49:2001;39-46.
33. Mayfield R.D., Lewohl J.M., Dodd P.R., Herlihy A., Liu J., Harris R.A. Patterns of gene expression are altered in the frontal and motor cortices of human alcoholics. J Neurochem. 81:2002;802-813.
34. Hata R., Masumura M., Akatsu H., et al. Up-regulation of calcineurin Abeta mRNA in the Alzheimer's disease brain: assessment by cDNA microarray. Biochem Biophys Res Commun. 284:2001;310-316.
35. Ho L., Guo Y., Spielman L., et al. Altered expression of a-type but not b-type synapsin isoform in the brain of patients at high risk for Alzheimer's disease assessed by DNA microarray technique. Neurosci Lett. 298:2001;191-194.
36. Colantuoni C., Jeon O.H., Hyder K., et al. Gene expression profiling in postmortem Rett Syndrome brain: differential gene expression and patient classification. Neurobiol Dis. 8:2001;847-865.
37. Whitney L.W., Becker K.G., Tresser N.J., et al. Analysis of gene expression in mutiple sclerosis lesions using cDNA microarrays. Ann Neurol. 46:1999;425-428.